CO62 Network Meta-Analysis (NMA) of Immuno-Oncology (IO) Treatments for First-Line (1L) Advanced or Metastatic Melanoma
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.134
https://www.valueinhealthjournal.com/article/S1098-3015(23)03264-3/fulltext
Section Title :
Section Order :
10771
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03264-3&doi=10.1016/j.jval.2023.09.134